Back to search results

CBT-I for Older African American Adults with Insomnia

This study is looking at Cognitive Behavioral Therapy for Insomnia (CBT-I) in older African American adults who have trouble sleeping. Insomnia is common, affecting about 25% of older adults. CBT-I is a treatment that doesn't use medicine; instead, it helps you change how you think and act about sleep to improve your sleep habits. The study will involve 20 participants. To join, you need to be an African American adult aged 60 or older, have a 6th-grade reading level or better, and be part of the "Pathways to Healthy Aging in African Americans" study. The main goal is to see how well participants stick with the CBT-I treatment over 8 weeks. The study's current status is unclear.

Study design
This interventional study plans to enroll 20 participants. It is testing Cognitive Behavioral Therapy for Insomnia (CBT-I) and sleep hygiene education.
What's involved
You would participate in 8 sessions of CBT-I, which includes education about sleep, changing thoughts about sleep, and establishing a consistent sleep schedule. There will also be one session focused on sleep hygiene education.
Compensation
Not stated in the trial record.
Follow-up
The study measures adherence from enrollment to the end of treatment at 8 weeks.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06791356

CBT-I in Older African American Adults

Recruiting
NAAges 60+InterventionalTreatment
Rutgers, The State University of New Jersey
~20 participants
Updated 2026-02-20 on ClinicalTrials.gov
What's tested:Cognitive-behavioral therapy for insomniaSleep hygiene education

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Adherence
Measured over From enrollment to the end of treatment at 8 weeks

Conditions

Older Adults (65 Years and Older)

Explore related trials

Insomnia

Where it's being run

1 sites across 1 states
New Jersey1

Study leadership

  • Mark Gluck, PhD · PRINCIPAL_INVESTIGATOR · Rutgers University

Who to contact

Payton White
[email protected]
(973)-353-6373
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Reading level 6th grade or better and can speak and understand English well.
Self-identify as African American or Black.
Ages 60 and over.
Score of \>2 in PSQI sleep duration, sleep disturbance, or overall sleep quality calculated components.
Participating in the "Pathways to Healthy Aging in African Americans" study.
Has established chronic insomnia issues for at least three months.
Subjects must be willing to participate in 8 sessions of CBT-I via Zoom for the CBT-I group.
Subjects must be willing to come for pre/post assessment visits.
MoCA score of between 20-26.

Exclusion

Currently taking any of the following medications consistently: Benzodiazepines (ProSom, Restoril, Ativan and Xanax); Z Drugs (eszopiclone (Lunesta), zaleplon (Sonata) and zolpidem (Ambien, Ambien CR, Edluar, and Zolpimist); antidepressants that affect sleep (doxepin, mirtazapine, trazodone); antihistamines (diphenhydramine and doxylamine succinate); barbiturates (methohexital, pentobarbital, primidone, secobarbital).
Diagnosed with any sleep disorder other than insomnia (i.e. obstructive sleep apnea using STOP-BANG, restless leg syndrome, REM sleep behavior disorder, etc.).
Classified as high fall risk.
Primary causes for frequent awakenings are due to a medical condition that is not related to insomnia, such as chronic pain, urinary frequency, upper respiratory infection.
Previous experience with CBT-I.

What this trial measures

  • AdherenceFrom enrollment to the end of treatment at 8 weeks

    Number of sessions completed, sleep diary completion rate